In Real World, Patients With Myeloma Have Worse Outcomes
A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.
Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.
An exploratory analysis reveals potential associations between a dietary intervention and both a reduction in postmenopausal vasomotor symptoms and changes in the gut microbiome.
Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.
Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in countries including Britain, Germany, Belgium and the United States.
The U.S. health regulator's staff on Wednesday flagged concerns that data on Merck's chronic cough drug might not be enough to prove the treatment's meaningful benefit.